BioCentury
ARTICLE | Clinical News

Bimatoprost SR: Interim Phase I/II data

November 23, 2015 8:00 AM UTC

Interim data from a 24-month Phase I/II trial in 75 patients with open-angle glaucoma or ocular hypertension showed that a single dose of 6, 10, 15 and 20 ug bimatoprost SR given via an intracameral i...